ID: ALA2207144

Max Phase: Preclinical

Molecular Formula: C7H11NO4

Molecular Weight: 173.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)COC(=O)[C@@H]1CCCN1

Standard InChI:  InChI=1S/C7H11NO4/c9-6(10)4-12-7(11)5-2-1-3-8-5/h5,8H,1-4H2,(H,9,10)/t5-/m0/s1

Standard InChI Key:  LYNHVQJBAXNJBW-YFKPBYRVSA-N

Associated Targets(Human)

Peptidyl-glycine alpha-amidating monooxygenase 90 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 173.17Molecular Weight (Monoisotopic): 173.0688AlogP: -0.63#Rotatable Bonds: 3
Polar Surface Area: 75.63Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.45CX Basic pKa: 7.45CX LogP: -2.94CX LogD: -3.18
Aromatic Rings: 0Heavy Atoms: 12QED Weighted: 0.56Np Likeness Score: 0.29

References

1. Morris KM, Cao F, Onagi H, Altamore TM, Gamble AB, Easton CJ..  (2012)  Prohormone-substrate peptide sequence recognition by peptidylglycine α-amidating monooxygenase and its reflection in increased glycolate inhibitor potency.,  22  (23): [PMID:23084901] [10.1016/j.bmcl.2012.10.004]

Source